Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries.

Saved in:
Bibliographic Details
Title: Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries.
Authors: Aymon, Romain1 romain.aymon@hcuge.ch, Mongin, Denis1, Guemara, Romain1, Salis, Zubeyir2, Askling, Johan3, Choquette, Denis4, Codreanu, Catalin5, Di Giuseppe, Daniela3, Flouri, Irini6, Huschek, Doreen7, Hyrich, Kimme L.8, Iannone, Florenzo9, Kvien, Tore K.10, Leeb, Burkhard F.11, Nordström, Dan12, Otero‐Varela, Lucia13, Pavelka, Karel14, Pombo‐Suarez, Manuel15, Rodrigues, Ana16, Rotar, Ziga17
Source: Arthritis & Rheumatology. Sep2025, Vol. 77 Issue 9, p1194-1204. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23265191
DOI:10.1002/art.43188